Please enter the email address you used to register, then we will send you a link to choose a new password
JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $152 to $...
Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered...
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from...
Citigroup analyst Patrick Donnelly maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $1...
UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $139 to $146.
Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target fro...
Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $150 to $155.
Latest financial insights from Quest Diagnostics. Q1 results beat estimates with adjusted EPS of $2.04 and sales of $2.34 billi...